日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Meta-analysis of multi-center transcriptomic profiles and machine learning reveal phospholipase Cβ4 as a Wnt/Ca²(+) signaling mediator in glioblastoma immunotherapy.

多中心转录组谱的荟萃分析和机器学习揭示了磷脂酶 Cβ4 是胶质母细胞瘤免疫疗法中的 Wnt/Ca²(+) 信号介质

Song Zhaoming, Wang Fei, Yang Chen, Guo Yanao, Li Jinfeng, Huang Run, Ling Hongyi, Cheng Guosheng, Chen Zhouqing, Zhu Zhanchi, Wang Zhong

Establishment and performance analysis of a new multiplex detection method for influenza an and B virus antigen

建立并分析一种新的甲型和乙型流感病毒抗原多重检测方法的性能

Xia, Cheng-Jing; Li, Bao-Hua; Guo, Yan-Ni; Zhou, Xiao-He; Zhang, Run-Ling; Niu, Ying-No

Structure-based discovery of a specific SHP2 inhibitor with enhanced blood-brain barrier penetration from PubChem database

从 PubChem 数据库中基于结构发现具有增强血脑屏障穿透能力的特定 SHP2 抑制剂

Ying Ma, Wei-Ya Li, Ting Sun, Ling Zhang, Xin-Hua Lu, Bing Yang, Run-Ling Wang

Asparagus cochinchinensis alleviates disturbances of lipid metabolism and gut microbiota in high-fat diet-induced obesity mice

芦笋可减轻高脂饮食引起的肥胖小鼠的脂质代谢和肠道菌群紊乱

Shiyue Luo, Lixiao Zhou, Xuejun Jiang, Yinyin Xia, Lishuang Huang, Run Ling, Shixin Tang, Zhen Zou, Chengzhi Chen, Jingfu Qiu

Prescription of statins at discharge and 1-year risk of major clinical outcomes among acute coronary syndromes patients with extremely low LDL-cholesterol in clinical pathways for acute coronary syndromes studies

在急性冠脉综合征临床路径研究中,出院时处方他汀类药物与极低密度脂蛋白胆固醇水平的急性冠脉综合征患者1年内发生主要临床事件的风险之间的关系

Sun, Yihong; Xie, Gaoqiang; Patel, Anushka; Li, Shenshen; Zhao, Wei; Yang, Xingzi; Wu, Tao; Li, Min; Li, Xian; Du, Xin; Hu, Rong; Huo, Yong; Hu, Dayi; Gao, Run Ling; Wu, Yangfeng

The design of novel inhibitors for treating cancer by targeting CDC25B through disruption of CDC25B-CDK2/Cyclin A interaction using computational approaches

利用计算方法,通过破坏 CDC25B-CDK2/细胞周期蛋白 A 相互作用,靶向 CDC25B 来设计治疗癌症的新型抑制剂。

Li, Hong-Lian; Ma, Ying; Ma, Ying; Li, Yu; Chen, Xiu-Bo; Dong, Wei-Li; Wang, Run-Ling

Molecular docking, 3D-QSAR and structural optimization on imidazo-pyridine derivatives dually targeting AT1 and PPARg

对靶向AT1和PPARγ的咪唑并吡啶衍生物进行分子对接、3D-QSAR和结构优化

Zhang, Jun; Hao, Qing-Qing; Liu, Xin; Jing, Zhi; Jia, Wen-Qing; Wang, Shu-Qing; Xu, Wei-Ren; Cheng, Xian-Chao; Wang, Run-Ling

Design, sythesis and evaluation of a series of 3- or 4-alkoxy substituted phenoxy derivatives as PPARs agonists

一系列 3- 或 4-烷氧基取代的苯氧基衍生物作为 PPARs 激动剂的设计、合成及评价

Jun Zhang, Xue-Jiao Wang, Xin Liu, Yi Huan, Miao-Miao Yang, Zhu-Fang Shen, Wen-Qing Jia, Zhi Jing, Shu-Qing Wang, Wei-Ren Xu, Xian-Chao Cheng, Run-Ling Wang

Identification of novel multitargeted PPARα/γ/δ pan agonists by core hopping of rosiglitazone

通过罗格列酮核心跳跃鉴定新型多靶点PPARα/γ/δ泛激动剂

Wang, Xue-Jiao; Zhang, Jun; Wang, Shu-Qing; Xu, Wei-Ren; Cheng, Xian-Chao; Wang, Run-Ling

Find novel dual-agonist drugs for treating type 2 diabetes by means of cheminformatics

利用化学信息学方法寻找治疗2型糖尿病的新型双重激动剂药物

Liu, Lei; Ma, Ying; Wang, Run-Ling; Xu, Wei-Ren; Wang, Shu-Qing; Chou, Kuo-Chen